RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • November 7th, 2018 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledNovember 7th, 2018 Company Industry JurisdictionThis RESEARCH COLLABORATION AGREEMENT (this “Agreement”) is entered into as of September 17, 2018 (the “Effective Date”) by and between, on the one hand, ViaCyte, Inc., a corporation organized and existing under the laws of Delaware, and CRISPR Therapeutics AG (“CRISPR”). ViaCyte and CRISPR each may be referred to herein individually as a “Party” or collectively as the “Parties.”